HomeNewsBusiness CornerResourcesProduct InformationContinuing EducationTechnologyLegislative

Update Profile
Site Map
Contact Us
Logout

Welcome !

Medicare DME Program

DME Alert Blog

 

Bill Popomaronis, R.Ph., NCPA vice president, home health and long term care pharmacy services, provides his thoughts and explanations on the latest DME information from CMS.


Thursday, May 8, 2008

Competitive Bid Final Jeopardy - What is 'that shows your usefulness as a witness?'

What Ways and Means Committee Chairman Pete Stark (D-CA) said when Acting CMS Commissioner Weems responded that he saw nothing that he would change about the DMEPOS Competitive Bidding Program.

posted by dme alert service @ 11:28 AM 

Bayer HealthCare, Diabetes Care, has underwritten the costs of this communication. The information expressed in this communication are the views of NCPA. Bayer is not responsible for the accuracy of the information expressed in this communication. Any questions related to DME Accreditation and/or Competitive Bidding for DMEPOS should be directed to the Centers for Medicare and Medicaid Services or NCPA.